Lumora

Lumora's MDx technology for the clinical and industrial sectors will be merged with ERBA Mannheim's IVD testing business in a wide range of market segments.

Roche is buying Lumora's heat elution technology, which enables nucleic acid isolation in minutes, as opposed to hours. 

NEW YORK (GenomeWeb News) – New England Biolabs today announced a manufacturing and supply agreement with molecular diagnostics firm Lumora.

Lumora said this week that it has appointed Hayden Jeffreys to its board of directors.

Scientists from UK-based molecular diagnostics developer Lumora have published a pilot study demonstrating how a new heat elution-based sample prep method can be combined with isothermal amplification and Lumora's bioluminescent assay in real-time (BART) readout technology to qui

Lumora and Promega said this week that they have signed an agreement for the use of Promega's Ultra-Glo luciferase in Lumora's bioluminescent assay in real time, or BART, molecular diagnostics technology.

NEW YORK (GenomeWeb News) – UK molecular diagnostics firm Lumora today announced a supply agreement with Promega for use of its luciferase in Lumora's Bioluminescent Assay in Real-Time, or BART, technology.

Lumora said this week that it has entered into a license and development agreement with Israel's Biogal Galed Labs ACS to develop a series of veterinary diagnostic tests.

NEW YORK (GenomeWeb News) – UK molecular diagnostics firm Lumora today announced a licensing deal to develop tests for veterinary diagnostics company Biogal Galed Labs.

A pair of recently published peer-reviewed studies has vetted the performance of a new test based on loop-mediated isothermal amplification, or LAMP, as a tool for the quick and easy diagnosis of malaria in both modernized laboratories and in the field in areas of the world where

Pages

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.